Related Experiment Video
Updated: Jan 4, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Responding to global stimulant use: challenges and opportunities
Michael Farrell1, Natasha K Martin2, Emily Stockings1
1National Drug and Alcohol Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia.
Global stimulant use, including cocaine and amphetamines, is linked to significant health harms like increased mortality and infections. Current interventions are largely ineffective, highlighting an urgent need for better treatments.
Area of Science:
- Public Health
- Epidemiology
- Substance Use Research
Background:
- Stimulant use, particularly cocaine and amphetamines, poses a significant global health challenge.
- Understanding the prevalence, associated harms, and effectiveness of interventions is crucial for public health strategies.
Purpose of the Study:
- To synthesize global data on stimulant use prevalence, harms, and interventions.
- To estimate the impact of cocaine and amphetamine use on mortality, suicidality, and blood-borne virus incidence.
Main Methods:
- Global literature review and data synthesis.
- Epidemiological modeling to estimate the effects of stimulant use on key health outcomes.
Main Results:
- Estimated global prevalence of cocaine use at 0.4% and amphetamine use at 0.7%.
- Stimulant use is associated with elevated mortality, increased HIV and Hepatitis C incidence, poor mental health, and cardiovascular risks.
- Dependence rates were 16% for cocaine users and 11% for amphetamine users.
Conclusions:
- Current pharmacotherapies are ineffective for reducing stimulant use; psychosocial interventions show limited effects, except for contingency management.
- Generic public health approaches require tailoring to mitigate stimulant-specific harms.
- Substantial investment is critical for developing effective stimulant use interventions.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Stimulants: Psychedelic Agents
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Global Regulatory Systems